Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
Top Cited Papers
- 6 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Archives of Oto-Rhino-Laryngology
- Vol. 277 (8), 2251-2261
- https://doi.org/10.1007/s00405-020-05965-1
Abstract
Objective To investigate the occurrence of olfactory and gustatory dysfunctions in patients with laboratory-confirmed COVID-19 infection. Methods Patients with laboratory-confirmed COVID-19 infection were recruited from 12 European hospitals. The following epidemiological and clinical outcomes have been studied: age, sex, ethnicity, comorbidities, and general and otolaryngological symptoms. Patients completed olfactory and gustatory questionnaires based on the smell and taste component of the National Health and Nutrition Examination Survey, and the short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS). Results A total of 417 mild-to-moderate COVID-19 patients completed the study (263 females). The most prevalent general symptoms consisted of cough, myalgia, and loss of appetite. Face pain and nasal obstruction were the most disease-related otolaryngological symptoms. 85.6% and 88.0% of patients reported olfactory and gustatory dysfunctions, respectively. There was a significant association between both disorders (p < 0.001). Olfactory dysfunction (OD) appeared before the other symptoms in 11.8% of cases. The sQO-NS scores were significantly lower in patients with anosmia compared with normosmic or hyposmic individuals (p = 0.001). Among the 18.2% of patients without nasal obstruction or rhinorrhea, 79.7% were hyposmic or anosmic. The early olfactory recovery rate was 44.0%. Females were significantly more affected by olfactory and gustatory dysfunctions than males (p = 0.001). Conclusion Olfactory and gustatory disorders are prevalent symptoms in European COVID-19 patients, who may not have nasal symptoms. The sudden anosmia or ageusia need to be recognized by the international scientific community as important symptoms of the COVID-19 infection.Keywords
This publication has 26 references indexed in Scilit:
- A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2019
- The Number of X Chromosomes Influences Inflammatory Cytokine Production Following Toll-Like Receptor StimulationFrontiers in Immunology, 2019
- Young Otolaryngologists of International Federation of Oto-rhino-laryngological Societies (YO-IFOS) committeesEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2018
- The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous systemThe Journal of Pathology, 2014
- Contemporary assessment of the prevalence of smell and taste problems in adultsThe Laryngoscope, 2014
- Virus Infections in the Nervous SystemCell Host & Microbe, 2013
- Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2Journal of Virology, 2008
- Identification of Viruses in Patients With Postviral Olfactory DysfunctionThe Laryngoscope, 2007
- Multiple organ infection and the pathogenesis of SARSThe Journal of Experimental Medicine, 2005
- Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2The EMBO Journal, 2005